Record Growth, Margin Recovery on Hold
Kross delivered an exceptional 80% revenue beat, but operating margins slipped further below target. The commodity pass-through that management promised is lagging, pushing the margin recovery story into H2 and beyond.
₹235.1 Cr
+79.6% YoY; beat 22% FY27 guide
₹19.7 Cr
+143.5% YoY
13%
vs 14–15% target; up 80 bps QoQ
Kross crushed growth targets — ₹235 crore revenue at 80% YoY is exceptional, and the ₹19.7 crore PAT translates to a 143% beat. The Q2 quarter itself reads as a triumph for the trailer axle segment, which is accelerating (₹116 Cr, 55% volume growth). Yet the headline masks a stubborn tension: operating margins hit 13%, still 100–200 basis points below the 14–15% target that management promised at the start of the year. The reason is blunt: commodity inflation — primarily steel — is rising faster than the company can pass it through to customers.
The margin gap: where the quarter sits
In Q1, Kross reported an OPM of 12.2%, which triggered the first miss against the 14–15% guidance. Management attributed the shortfall to commodity lag — steel prices were climbing, but the company had only secured partial price compensation from OEMs and Tier 1 customers by April. Q2 improved by 80 basis points to 13%, which sounds like traction, but the target remains 100–200 basis points away. The core problem has not resolved: steel is still rising every quarter, and customer settlements for Q3 onwards are still underway. This is not a quarter of margin recovery; it is a quarter of margin stabilisation while waiting for pass-through negotiations to settle.
Steel has been increasing every quarter. There has been only a part compensation on steel as a commodity, which we received in Q1. There will be further — in Q1 and Q2, both, there is just a part of it.
What changed from Q1
The growth story dramatically accelerated. In Q1, Kross's reaffirmed guidance of 22% FY27 growth was implicit (management said Q1 was "in line with targets"). Q2 delivered 80% revenue growth YoY, which implies the first half of FY27 is now tracking at approximately 55% cumulative growth. This is not a guidance beat — it is a guidance smash. The demand drivers are visible: the trailer axle segment is firing on all cylinders, gaining market share with new and existing OEM customers. Tractor axles are accelerating post-monsoon. Exports are growing 45% YoY. The extruded axle rollout is 80% complete, and customer feedback is positive. This is real, earned growth, not a supply-side anomaly or one-time order. On the margin front, the story remains incomplete. The company is 80 basis points better quarter-on-quarter but still 100–200 basis points behind the target. Management maintains that Q3+ settlements will close this gap, but the lag from inflation to pass-through is proving longer than the January call assumed.
Revenue growth 80% YoY
₹235.1 Cr, 79.6% YoY (effectively 80%)
Supported
PAT growth 143% YoY
₹19.7 Cr, 143.5% YoY
Supported
OPM improving to 13%; on track to 14–15%
OPM 13% (up 80 bps QoQ). Still 100–200 bps below target; timeline to target pushed to Q3+
Partially supported — improvement real, but target receding
Trailer segment 55% growth, momentum sustained
Trailer axles ₹116 Cr Q2, 55% volume growth YoY. New OEM and Tier 1 customers added
Supported
Seamless tube facility on track for Q4 FY27 production trials
Phase 1 equipment mostly received. Production trials Feb/March 2027 (Q4 FY27 window)
Supported
Receivable days normalising post-bull cycle
Q2 ~81 days, H1 ~90 days (vs ~70 historical). Improving from H1 FY26 ~150 days, but still elevated
Partially supported — improving but lag risk remains
The bull-bear ledger
Revenue growth beats guidance massively (80% actual vs 22% implied). Demand environment stronger than prior call.
Trailer axle segment emerging as 49% of revenue, growing 55% YoY. Real market share gains, not capacity anomaly.
Seamless tube capex deploying on schedule (₹60 Cr H1 of ₹170 Cr total). Execution credible.
Backward integration strategy concrete: 3–4% OPM uplift modelled for H2 FY28 once Phase 1 ramps.
Operating margins 100–200 bps below target. Commodity pass-through lag longer than expected.
Working capital cycle stretched. Receivable days ~90 (vs ~70 historical). Cash conversion drag with growth.
Seamless tube capex ₹170 Cr is large. Delays would defer margin recovery to H2 FY28 or later.
Customer concentration ~15–16% top line in single OEM/Tier 1. Loss of major order would materially impact revenue.
Ranked risks for a holder
Commodity inflation persists; pass-through stalls longer than Q3+
HighMargins locked at 12–13% for longer. The 14–15% target becomes a FY28+ target. Valuation multiple at risk if margins stay compressed through CY27.
Working capital cycle stress (receivable days ~90 days) impairs cash conversion
MediumGrowth is rapid, but cash generation is lagged. Company may need to tap credit facilities or slow capex if receivables do not normalize post-bull cycle.
Seamless tube capex execution delays Phase 1 production or ramp-up
Medium₹170 Cr project critical for FY28+ margin recovery. Delays push the 3–4% OPM uplift out further, delaying return to target.
Customer concentration ~15–16% top line. Loss of major OEM or order cancellation
LowWould materially reduce near-term revenue. Mitigated by diversified product base and new customer wins (Europe, tractor axles, exports).
Tractor segment seasonality; post-Diwali demand assumes normal farm income and rainfall
LowSeasonal cyclicality. Mitigated by trailer segment (less seasonal, growing faster) and export business (+45% YoY).
The street's lens: price, ownership, flows
Kross is trading at ₹278.3, comfortably above its 20-day (₹262.52), 50-day (₹234.37), and 200-day (₹203.31) moving averages. The stock is up 85% from its 52-week low and sits 15% below its all-time high of ₹326.4. This is a bullish structure — above all key averages, in an uptrend — but the pulldown from the peak suggests the market has already priced in some of the growth excitement. RSI at 60.3 is neutral; volume is increasing post-result, indicating sustained institutional interest. On ownership, FII holdings are flat QoQ at 2.51%, and DII is flat at 6.05%. This is not a stampede of foreign money, nor a domestic institutional rout. The promoter holds steady at 68.57%, a vote of confidence but not a surprise for a founder-led auto supplier. Recent bulk deals show institutional funds active around ₹304–308 per share — notably above the current spot price. This suggests profit-taking or rebalancing after the post-result pop, rather than conviction buying at the current level. The stock may be consolidating after the run-up, not yet ready for the next leg.
The debate
Bull case: Revenue growth of 80% annualises to a ₹940 Crore annualised run-rate on a ₹235 base, implying the company has shifted to a sustainably higher growth trajectory. Trailer axles are becoming a real profit engine. The seamless tube facility is a structural margin solution: 3–4% OPM uplift, quantified and dated (H2 FY28). Capex is deploying on schedule. Valuation at 28–30x forward P/E on 40%+ growth is reasonable for a mid-cap auto supplier with backward integration upside. The stock should re-rate higher once Q3 confirms the commodity pass-through. Bear case: The margin miss is real and persistent. Q1 missed by 230 basis points, Q2 improved only 80 basis points. At this pace, the 14–15% target is a FY28 target, not a Q3+ target. If capex delays or commodity volatility extends, margins stay at 11–13%, which breaks the bull case. Working capital is stretched (90+ day receivables), impacting cash generation. The stock is not a bargain at ₹278 — it is priced for perfection on the capex and commodity timing. The honest read: Kross is a genuine step-change growth story (80% revenue growth, real demand drivers), hampered by near-term margin pressure (commodity lag). The company has a credible plan to fix margins (₹170 Cr seamless tube capex, 3–4% uplift, Q4 FY27 → H1 FY28 timeline). Management is executing — capex is on schedule, segments are accelerating. But the margin recovery is 2–3 quarters out, not immediate. At ₹278, the stock is fairly valued for the growth + the capex upside, conditional on Q3–Q4 proving the commodity pass-through narrative. Hold for conviction, watch for Q3 EBITDA data.
What to watch next
1 · Q3 FY27 EBITDA margin
This is the litmus test for commodity pass-through. Management promised Q3+ settlements with OEMs and Tier 1s. If OPM expands by 100+ basis points QoQ (to 14%+), the margin recovery narrative holds. If it stalls or dips, the pass-through is stalled and the margin target recedes further.
2 · Seamless tube Phase 1 capex progress
Watch for equipment receipt milestones in Nov–Dec 2026, and production trial readiness by Feb–March 2027. Any delays here push the margin recovery story out of H2 FY28.
3 · Receivable days normalization
Are they falling back to ₹70 days as management promised? If receivable days stay at 90+ through Q3, it signals that the CV segment bull-cycle is not cooling, and working capital intensity remains elevated. This impairs cash generation and could force the company to tap credit facilities or slow capex.
The single number to track
Operating margin in Q3 FY27. That is the verdict on commodity pass-through. If it hits 14%+, the margin recovery is real and Q4 becomes a momentum print. If it stalls at 13%, the bull case is deferred to H2 FY28, and the stock stays range-bound through CY27.
Kross delivered an exceptional growth quarter (80% revenue, 143% PAT) but left the margin recovery story unfinished. The company is spending ₹170 Crore to fix margins, and execution is credible so far. But near-term margin compression (13% vs 14–15% target) and working capital stress mean the upside is conditional on Q3+ proving the commodity pass-through and capex delivering on time.
This is not a screaming buy or a sell. It is a hold for conviction holders, a wait for new money. The growth is real, the capex plan is concrete, but the margin recovery is 2–3 quarters out. The next quarter will settle whether Kross is a near-term margin recovery play or a long-term capex story.
Record growth masks commodity-driven margin compression; structural relief imminent
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Missed Q1 EBITDA margin target (12.2% vs 14-15%), Q2 improved to 13% but still below. Growth exceeded implicit 22% target; trajectory credible.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Q2 crushed growth targets (80% revenue, 143% PAT vs. 22% FY27 implied guide), driven by trailer/tractor momentum and new products (extruded axles). OPM improved QoQ (12.2% → 13%) but fell short of 14-15% target; commodity inflation absorbed costs, pass-through staggered to Q3+. Seamless tube facility on track for Q4 trials, poised to unlock 3-4% margin expansion. Valuation and execution risk on ₹170 Cr capex temper near-term upside; long-term structural leverage is real.
₹235 Cr
Revenue · +80% YoY₹19.69 Cr
Reported PAT · +143% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 revenue 80% YoY growth, exceptional momentum
METDelivered 235.1 Cr, 79.6% YoY (delivered slightly lower but effectively 80%)
PAT 143% YoY, margins improving
METDelivered 19.7 Cr, 143.5% YoY; OPM 13% vs 12.2% Q1, but below 14-15% target
Seamless tube facility on track for Q4 FY27 production trials
METManagement confirmed Feb/March 2027 production trials; Phase 1 equipment mostly received by Nov/Dec
Trailer segment 55% volume growth; expects Q3/Q4 to be stronger than Q2
METQ2 trailer volume growth vs H1 ₹55% segment growth confirmed; Q3/Q4 expected stronger, tractor demand high post-Diwali
Commodity cost inflation only partially passed through; margin compression imminent
METSteel rising every quarter, only partial compensation from OEMs/Tier 1s so far; settlements underway for Q3+
Earnings quality
What changed since the last call
Revenue growth trajectory
UpgradeQ1 showed 22% implied growth target; Q2 delivered 80% actual growth. H1 FY27 cumulative 55% growth vs prior year. Demand environment stronger than prior call guidance.
EBITDA margin near-term
DowngradeQ1 12.2% vs 14-15% target = 230 bps miss; Q2 13% improves 80 bps but still 100-200 bps short. Commodity inflation proved more persistent than expected in Q1 call.
Capex timeline
NeutralSeamless tube facility remains on track for Q4 FY27 trials (Feb/March 2027), ~₹60 Cr deployed in H1, ₹110 Cr pending in H2 via warrants/pref shares. No delay vs Q1 guidance.
Segment momentum
UpgradeTrailer axle segment +55% Q2 vs H1 prior year; OEM and Tier 1 demand stronger. Extruded axle rollout 80% complete; tractor axle and exports also accelerating.
The Q&A
Analysts pressed hard on commodity cost pass-through timing, capex execution, and receivable days stress. Management held firm on seamless tube schedule, acknowledged capex risk but noted equipment mostly in-house, and defended receivable days as temporary (CV segment working capital stretch; improving). No major evasion except on exact FY28 EBITDA margin guidance (cited commodity volatility).
Segment growth drivers — Anubhav Mukherjee, Prescient Capital
AnsweredMonsoons ended, demand picked up in Aug. Trailer segment saw strong OEM sales, tractor axle growth due to higher market share, exports +45% YoY. Suspension (mechanical + air) drastic increase in Q2.
Extruded axle adoption — Anubhav Mukherjee, Prescient Capital
Answered80% of axles now use extrusion process, 20% conventional. Feedback positive from fabricators; process benefits understood. Mass rollout started Aug, feedback positive, benefits to be seen over time.
Receivables cycle — Anubhav Mukherjee, Prescient Capital
PartialCV segment stretch due to bull cycle; will come down. H1 last year H1 FY26 150 days, now ~90 days overall, ~81 days Q2. Improving trajectory expected as demand normalizes.
Axle capacity utilization — Pritesh Chheda, Lucky Investment
Answered4,500 existing capacity currently at 80% utilization with extruded axles. 7,500 is expanded capacity coming online; will scale next quarters. Not about 4,500 of expanded; 4,500 of existing.
Volume growth breakdown — Pritesh Chheda, Lucky Investment
AnsweredTrailer axle: 10,500+ units Q2 (vs ~9,500 Q1), ~55% growth vs H1 FY26. Suspension: drastic increase, ~20,000 units crossed H1. Volume growth 55%+ QoQ and YoY.
Tipping jacks segment — Ankur Poddar, Svan Investment
AnsweredSimilar volumes to Q1, ~800 units capacity per quarter. Revenue per unit ~₹1.4 lakh. Set a capacity of 800; utilization ~50-60% by Q4.
Agri segment outlook — Ankur Poddar, Svan Investment
AnsweredQ3 expected strong (post-Diwali); tractor demand seasonal. Exports (8% of component business) growing at 45% YoY. Lower inventory levels supporting demand.
Cold drawn tubes (seamless) strategy — Ankur Poddar, Svan Investment
Answered₹125 Cr (~₹170 Cr total budgeted). Phase 1: ~₹50-60 Cr (internal + ₹110 Cr term loan). Phase 1 backward integration only. Precision for auto components and tipping jacks. Capex ~₹24 Cr per set. 8-10% margin improvement in seamless vs hot drawn.
Trailer axle momentum — Shubham Bhatra, Ambit Asset
Answered55% QoQ growth, ~₹116 Cr Q2 revenue. Expect sustained momentum Q3/Q4. Chhattisgarh strong region. Gaining market share with existing and new customers.
Regional penetration — Shubham Bhatra, Ambit Asset
PartialContinuous expansion. Chhattisgarh strong. No specific region lagging; every region contributing post-GST rationalization.
Seamless tube capex details — Shubham Bhatra, Ambit Asset
Answered₹170 Cr total budgeted (not ₹120 Cr). ₹110 Cr term loan + ₹60 Cr internal accruals. Already spent ~₹50 Cr H1, planned ₹120 Cr next 6 months. ₹120 Cr cash impact Q2 only.
Total capex and funding for FY27 — Vignesh Iyer, Sequent Investments
Answered~₹60 Cr H1 capex (seamless tube only). H2 planned ₹110 Cr via warrant/pref shares for increased CV demand. Shaft lines and robotic automation also in H2.
Debt trajectory — Rajat Aggarwal, Nilgiri Advisors
AnsweredSeamless tube term loan ₹110 Cr (₹110 Cr available, will draw as needed). Total debt end FY27 ~₹115 Cr. No further expansion debt beyond seamless. Working capital debt ~₹32 Cr.
Export expansion — Rajat Aggarwal, Nilgiri Advisors
AnsweredDirectly sold to OEMs and Tier 1s. Added new European customer for propeller shaft parts (validation stage, not mass production yet).
Volume numbers Q2 — Dhwanil Shah, i-Wealth Fund
AnsweredAxle: >10,000 units Q2 (vs 9,500 Q1), 50-60% suspension volume growth. Commodity costs up; expecting OEM/Tier 1 price increases. Will share detailed numbers separately.
Competitive landscape — Dhwanil Shah, i-Wealth Fund
AnsweredTrailer: York, Tata Motors, BPW, Hendrickson. Component: diversified competitors per product. No single competitor dominant. Fragmented market.
Seamless tube margin improvement — Dhwanil Shah, i-Wealth Fund
AnsweredPhase 1 for backward integration only, ~30% of 1 lakh capacity. Complete by end H1 FY28. 3-4% margin improvement expected with seamless tubes.
Margin guidance and commodity pressure — Anubhav Mukherjee, Prescient Capital
DodgedDifficult to guide due to commodity volatility. Settlements underway with OEMs/Tier 1s for Q3+. Further steel increases expected but hoping for pass-through.
Guidance
FY27: 22%+ growth (implicit reaffirm)
HighH1 FY27 already 55% growth; full-year 22% implies H2 moderation, but management tone suggests sustained momentum. On track vs. guidance.
EBITDA 14-15% target (from Q1 call)
MediumQ1 missed (12.2%), Q2 improved to 13%, still 100-200 bps short. Commodity pass-through Q3+ expected. Seamless tubes 3-4% uplift H2 FY28.
Seamless tube facility ₹170 Cr total (Q4 FY27 trials)
High₹60 Cr deployed H1, ₹110 Cr pending H2. Phase 1 on track Feb/March 2027 production trials. No delays reported.
H2 capex ₹110 Cr via warrants/pref shares
MediumShaft lines, robotic automation, seamless tube Phase 2. Funding plan clear; execution risk standard for capex projects.
Risks the call surfaced
Commodity cost inflation
MediumSteel prices rising every quarter; Q2 only partial compensation achieved. Q3+ settlements underway but lag risk. Margins may stay compressed longer than 14-15% target.
Working capital cycle strain
MediumReceivable days elevated (~81-110 days for CV segment vs 70 days historical). Growth in trailer segment (higher receivable days) straining working capital. Cash conversion temporarily impaired; may require increased credit facilities.
Seamless tube capex execution
Medium₹170 Cr seamless tube facility is large capex; delays would defer 3-4% margin uplift to H2 FY28 or later. Equipment in transit; Phase 1 production trials planned Feb/March 2027.
Customer concentration
LowLargest customer ~15-16% of top line. Concentration in OEM/Tier 1 segment. Loss of major customer or order cancellation would materially impact revenue.
Tractor axle demand seasonality
LowTractor axle demand seasonal (post-Diwali strong, monsoon weak). Dependent on farm income, rainfall, interest rates, government subsidies. Q3/Q4 strength assumed but not guaranteed.
Management
Score 8/10. Detailed, data-driven Q&A with specific numbers (₹1.4 lakh per tipping jack, 80% extruded axle rollout, 90-day receivables). Transparent on challenges (commodity inflation, margin gap). Slight evasion on exact FY28 EBITDA margin guidance citing commodity volatility — prudent but less specific. Seamless tube facility on schedule (Feb/March 2027 trials). H1 capex deployed as planned (₹60 Cr). Q2 growth massively beat implied 22% target (80% actual). Track record strong; credible on delivery.
1 · Feb–Mar 2027
Seamless tube facility Phase 1 production trials begin
2 · Q3 FY27
Tractor axle demand post-Diwali; commodity pass-through settlements conclude
3 · Q4 FY27
Seamless tube ramp-up; backward integration margin lift begins
Valuation and execution risk on ₹170 Cr capex temper near-term upside; long-term structural leverage is real.
Kross Q2 FY27: standalone PAT up 143% YoY to ₹19.7 Cr as margins expand toward guided range
PAT +143.5% YoY · revenue +79.6% · margins expanding · beat vs street
₹235.09 Cr
+79.6% YoY
₹19.69 Cr
+143.5% YoY
8.3%
+2.2pp YoY
₹3.08
Kross Limited's standalone revenue from operations for Q2 FY27 (quarter ended September 30, 2026) came in at ₹235.09 Cr, up 79.6% YoY from ₹130.92 Cr and 27.5% QoQ from ₹184.34 Cr. Net profit rose even faster, up 143.5% YoY to ₹19.69 Cr from ₹8.09 Cr, and 47.9% QoQ from ₹13.31 Cr, taking basic EPS to ₹3.08 (not annualised) from ₹1.25 a year ago and ₹2.06 last quarter. The company has no subsidiaries, so this standalone print is also the only set of numbers — there is no consolidated divergence to reconcile.
Q2 FY-2027 vs prior quarters
The profit growth outpaced revenue because margins expanded on both counts: operating margin (EBITDA/revenue) rose to roughly 13.9% from about 12.1% a year ago and 12.4% last quarter, while net margin widened to 8.37% from 6.13% YoY and 7.21% QoQ. This directly validates what management flagged on the Q1 FY27 call — that the 12.2% EBITDA margin delivered in Q1, below its 14-15% guided band, was a commodity-cost lag that would reverse as pass-through kicked in from Q2 onward. The margin did move up sequentially as promised, though at ~13.9% it is still short of the top of the guided range, so the pass-through appears to be working but isn't fully complete.
The stock went into the print at ₹272, up 20.4% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
No formal FY27 re-guidance. Implicitly on track: reaffirmed 22% growth target via 'Q1 in line of targets.' EBITDA 14-15% guide missed in Q1 (12.2% delivered) due to commodity lag, but management expects pass-through in Q2+. Seamless tube facility expected Q4 FY27; ₹125 Cr CAPEX on track.
— This quarter: beat
On growth, the quarter runs far ahead of the only formal marker on record: management's reaffirmed FY27 target of ~22% growth, made on the back of Q1's in-line performance. H1 FY27 revenue of ₹419.43 Cr is up 55.2% YoY and H1 PAT of ₹33.16 Cr is up 76.6% YoY — both multiples of the stated target, making this a clear beat on guidance even as the margin trajectory is only now catching up. No formal sell-side consensus for this specific quarter could be confirmed; the closest available marker, an independent pre-earnings preview, had flagged whether revenue could sustain near the ₹225 Cr peak seen in March 2026 and whether OPM could hold in the mid-teens — the actual ₹235 Cr print tops that prior peak and OPM of ~13.9% sits just under the mid-teens bar, which reads as a beat on the informal expectation set. No separate management press release accompanied this filing, so there is no additional management commentary to cross-check against the print beyond the board outcome letter and notes.
W1
Whether OPM closes the gap to management's guided 14-15% EBITDA margin band from the current ~13.9%
W2
Commissioning of the seamless-tube facility targeted for Q4 FY27, backed by the ₹125 Cr capex plan (₹59.16 Cr spent in H1)
W3
Completion of the preferential allotment (15,00,000 shares + 15,00,000 warrants), currently pending stock-exchange in-principle approval
Standalone only — Kross has no subsidiary/associate/JV, so consolidated statement is not prepared (filing Note 5). Source in ₹ Millions, converted to ₹ Crore (÷10). No exceptional items this quarter; year-ago quarter carried an immaterial ₹0.12 Cr prior-year tax true-up, not large enough to warrant adjusted-PAT treatment.